FREE SHIPPING ON ORDERS OVER $150

retatrutide ly3437943 glp-1 gip glucagon just posted the biggest weight-loss numbers ever recorded for a drug — 28.3% (≈70 lb) average in Phase 3, with 45% of people hitting 30%+ loss, territory once reserved for bariatric Medscape | The investigational triple

$26.34

Quantity
- +
Description

CMAJ, 196 (43), E1413

retatrutide ly3437943 glp-1 gip glucagon just posted the biggest weight-loss numbers ever recorded for a drug 28.3% (70 lb) average in Phase 3, with 45% of people hitting 30%+ loss, territory once reserved for bariatric Medscape | The investigational triple

After discontinuing Semaglutide (Wegovy) Injection, it is possible for some weight regain to occur if lifestyle modifications are not maintained

retatrutide ly3437943 glp-1 gip glucagon just posted the biggest weight-loss numbers ever recorded for a drug 28.3% (70 lb) average in Phase 3, with 45% of people hitting 30%+ loss, territory once reserved for bariatric Medscape | The investigational triple

Beinaglutide is not shown because marketing approval is restricted to China

retatrutide ly3437943 glp-1 gip glucagon just posted the biggest weight-loss numbers ever recorded for a drug 28.3% (70 lb) average in Phase 3, with 45% of people hitting 30%+ loss, territory once reserved for bariatric Medscape | The investigational triple

Ozempic is the brand name for semaglutide, a popular treatment option for managing Type 2 diabetes that is well-known for its off-label use for weight loss

retatrutide ly3437943 glp-1 gip glucagon just posted the biggest weight-loss numbers ever recorded for a drug 28.3% (70 lb) average in Phase 3, with 45% of people hitting 30%+ loss, territory once reserved for bariatric Medscape | The investigational triple

Resistance training and adequate protein intake should be prioritized, with monitoring of muscle mass and function during GLP-1RA treatment

retatrutide ly3437943 glp-1 gip glucagon just posted the biggest weight-loss numbers ever recorded for a drug 28.3% (70 lb) average in Phase 3, with 45% of people hitting 30%+ loss, territory once reserved for bariatric Medscape | The investigational triple

[DOI] [PubMed] [Google Scholar] 106.Butsch W.S., Kushner R.F., Alford S., Smolarz B.G

retatrutide ly3437943 glp-1 gip glucagon just posted the biggest weight-loss numbers ever recorded for a drug 28.3% (70 lb) average in Phase 3, with 45% of people hitting 30%+ loss, territory once reserved for bariatric Medscape | The investigational triple

You may also like

recommand products